Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands

Fig. 2

Dose of inhaled corticosteroids prescribed on the initiation date*. Reported doses are the actual dose for extrafine-particle ICS (ciclesonide or EF-HFA-BDP) and the fluticasone-equivalent dose for fine-particle ICS (fluticasone and Non-EF-BDP). * Initiation date: the date when patients received their first prescription of extrafine-particle ICS (ciclesonide or EF-HFA-BDP), or fine-particle ICS (fluticasone or Non-EF-BDP)

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us